Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: cholinesterase inhibition and cognition
Also known as: Galantamine hydrobromide
Galantamine is an acetylcholinesterase inhibitor and nicotinic receptor modulator, FDA-approved for mild-to-moderate Alzheimer's disease. Separately, a double-blind, placebo-controlled, crossover study found pre-sleep galantamine significantly increased the rate of lucid dreaming: 27% of participants reported a lucid dream at 4mg (odds ratio 2.29) and 42% at 8mg (odds ratio 4.46), compared to 14% on active placebo - a genuine RCT finding, distinct from its approved Alzheimer's indication.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Data source: Current approved label and randomized sleep study
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
4 mg twice daily for at least four weeks then 8 mg twice daily
Context: DailyMed galantamine label
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Use only in the cited label or guideline context; route, formulation, indication, and patient-specific limits still apply.
4 mg or 8 mg after approximately 4.5 hours of sleep
Context: lucid-dreaming crossover study PMCID PMC6082533
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Non-human or laboratory exposure. It cannot be converted into a human dose.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Reflects patterns reported in research/community literature only. Not a safety guarantee, medical advice, or interaction warning for human use.
This is an approved prescription drug; bulk-powder sizes should not replace labeled tablet and ER-capsule strengths.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.